The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure
Open accessAbstract
BACKGROUND: Non-communicable diseases (NCDs) represent a significant threat to human health and well-being, and carry significant implications for economic development and health care and other costs for governments and business, families and individuals. Risks for many of the major NCDs are associated with the production, marketing and consumption of commercially produced food and drink, particularly those containing sugar, salt and transfats (in ultra-processed products), alcohol and tobacco. The problems inherent in primary prevention of NCDs have received relatively little attention from international organizations, national governments and civil society, especially when compared to the attention paid to secondary and tertiary prevention regimes (i.e. those focused on provision of medical treatment and long-term clinical management). This may in part reflect that until recently the NCDs have not been deemed a priority on the overall global health agenda. Low political priority may also be due in part to the complexity inherent in implementing feasible and acceptable interventions, such as increased taxation or regulation of access, particularly given the need to coordinate action beyond the health sector. More fundamentally, governing determinants of risk frequently brings public health into conflict with the interests of profit-driven food, beverage, alcohol and tobacco industries. MATERIALS: We use a conceptual framework to review three models of governance of NCD risk: self-regulation by industry; hybrid models of public-private engagement; and public sector regulation. We analyse the challenges inherent in each model, and review what is known (or not) about their impact on NCD outcomes. CONCLUSION: While piecemeal efforts have been established, we argue that mechanisms to control the commercial determinants of NCDs are inadequate and efforts at remedial action too limited. Our paper sets out an agenda to strengthen each of the three governance models. We identify reforms that will be needed to the global health architecture to govern NCD risks, including to strengthen its ability to consolidate the collective power of diverse stakeholders, its authority to develop and enforce clear measures to address risks, as well as establish monitoring and rights-based accountability systems across all actors to drive measurable, equitable and sustainable progress in reducing the global burden of NCDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Trade agreements and liberalization were described as contributing to worsened health outcomes [16, 24, 31, 34, 36, 41, 43, 44].”
From Defining the commercial determinants of health: a systematic review (2020) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Corporate rights, including intellectual property rights, were described as presenting challenges to many interventions that could benefit public health [16, 33, 34, 43].”
From Defining the commercial determinants of health: a systematic review (2020) · cites this paper as [16]
The cited source says what the claim attributes to it.
In the citing paper
“Most commonly, CDoH were described as resulting from expressions of economic and political power wielded by large corporate entities, described as “powerful economic operators” [16, 19, 30, 35].”
From Defining the commercial determinants of health: a systematic review (2020) · cites this paper as [16]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Indeed, the WHO has called on member states to develop appropriate multi-sectoral approaches to deal with the marketing of foods and non-alcoholic beverages to children.136”
From Oral diseases: a global public health challenge (2019) · cites this paper as [136]
Experimental — accuracy not yet measuredIn the citing paper
“Overall, it was emphasized that powerful private sector interests commonly prevail over public health governance and accountability measures [5, 16, 38, 39].”
From Defining the commercial determinants of health: a systematic review (2020) · cites this paper as [16]
16 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transforming Our World: The 2030 Agenda for Sustainable Development
(2018) · A New Era in Global Health · doi:10.1891/9780826190123.ap02 · Cited by 19,351
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Global strategy on diet, physical activity and health
Samuelson, G. (2004) · Food & Nutrition Research · doi:10.3402/fnr.v48i2.1503 · Cited by 2,319
Economic Costs of Diabetes in the U.S. in 2012
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc12-2625 · Cited by 2,163
Moodie, R., Stuckler, D., Monteiro, C., Sheron, N., Neal, B., Thamarangsi, T., Lincoln, P., & Casswell, S. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62089-3 · Cited by 1,663
Health warning messages on tobacco products: a review
Hammond, D. (2011) · Tobacco Control · doi:10.1136/tc.2010.037630 · Cited by 1,162 · cited 1×
“been found to have some positive impact on tobacco control [50]) was more likely to occur in those countries that “avoided agreements with the tobacco industry in”
BackgroundThe commercial determinants of health
Kickbusch, I., Allen, L., & Franz, C. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30217-0 · Cited by 782
Private Power, Public Law: The Globalization of Intellectual Property Rights
Sell, S. K. (2003) · Cambridge University Press eBooks · doi:10.1017/cbo9780511491665 · Cited by 768 · cited 1×
“Similarly, the 1994 WTO adoption of the Trade-Related Aspects of Intellectual Property Rights – which dictates how states should regulate intellectual property protection – was the direct result of lobbying by powerful multinational corporations who succeeded in shaping international law to protect their markets [80].”
BackgroundThe political origins of health inequity: prospects for change
Ottersen, O. P., Dasgupta, J., Blouin, C., Buss, P., Chongsuvivatwong, V., Frenk, J., Fukuda-Parr, S., Gawanas, B. P., Giacaman, R., Gyapong, J., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62407-1 · Cited by 683 · cited 4×
“In addition, WHO’s financial insecurity may be creating new space for the engagement of the food and beverage industry [26].”
BackgroundInfluential
Research works printed but not linked: 6
- Chan, M. Opening address at the 8th Global Conference on Health Promotion, Helsinki, Finland, 10 June 2013. Geneva, World Health Organization. Available at: http://www.who.int/dg/speeches/2013/health_promotion_20130610/en/ . Accessed 17 Apr 2017.
- International Diabetes Federation. IDF Diabetes Atlas 7th edition 2015. Brussels: IDF; 2015.
- Bloom D, Cafiero E, Jané-Llopis E, Abrahams-Gessel S, Bloom L, Fathima S, et al. Harvard School of Public Health, world economic Forum. Global economic burden of noncommunicable diseases. Geneva: WEF; 2011.
- Moodie R, Stuckler D, Monteiro C, Sheron N, Neal B, Thamarangsi T, Lincoln P, Casswell S, on behalf of The Lancet NCD Action Group. Profits and pandemics: prevention of harmful effects of tobacco, alcohol and ultra-processed food and drink industries. Lancet. 2013;381(9867):670-9. · DOI · Paper page
- World Health Organization. Information note: participants of the WHO global coordination mechanism on the prevention and control of NCDs (WHO GCM/NCD), September 25 2014; 2014.
- Flores W. Accountability and Monitoring in Health Initiative, Open Society Foundation. Community monitoring for accountability in health: review of literature. 2011. Available at: http://health.accel-it.lt/assets/110718%20Johanesburg/Literature%20review_Community%20Monitoring%20Social%20Accountability%20in%20Health.pdf . Accessed 15 Nov 2015.
Cited by
Oral diseases: a global public health challenge
Peres, M. A., Macpherson, L. M. D., Weyant, R. J., Daly, B., Venturelli, R., Mathur, M. R., Listl, S., Celeste, R. K., Guarnizo-Herreño, C. C., Kearns, C., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31146-8 · Cited by 4,054
“17 public finances available for health improvement interventions.(128) Particularly 509 relevant for oral health polices is the case of the global sugar industry (Panel).”
BackgroundInfluentialThe Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report
Swinburn, B. A., Kraak, V. I., Allender, S., Atkins, V. J., Baker, P. I., Bogard, J. R., Brinsden, H., Calvillo, A., De Schutter, O., Devarajan, R., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32822-8 · Cited by 3,081
Understanding the rise of cardiometabolic diseases in low- and middle-income countries
Miranda, J. J., Barrientos-Gutiérrez, T., Corvalan, C., Hyder, A. A., Lazo-Porras, M., Oni, T., & Wells, J. C. K. (2019) · Nature Medicine · doi:10.1038/s41591-019-0644-7 · Cited by 365
Ng, M., Dai, X., Cogen, R. M., Abdelmasseh, M., Abdollahi, A., Abdullahi, A., Aboagye, R. G., Abukhadijah, H. J., Adeyeoluwa, T. E., Afolabi, A. A., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01548-4 · Cited by 344
“Structural determinants need to be addressed with structural interventions (ie, legislative changes to address commercial determinants 67 ) if we are to avoid the currently forecasted 2050 rates of overweight and obesity.”
An overview of the commercial determinants of health
Mialon, M. (2020) · Globalization and Health · doi:10.1186/s12992-020-00607-x · Cited by 276
Metadata
- Authors
- Buse, K., Tanaka, S., & Hawkes, S.
- Affiliations
- Joint United Nations Programme on HIV/AIDS (CH)
- University College London (GB)
- Corresponding author
- Hawkes, Sarah
- Venue
- Globalization and Health
- Published
- 2017-06-15
- Volume
- 13
- Issue
- 1
- Pages
- 34-34
- ISSN
- 1744-8603 (ISSN-L)
- PMC
- PMC5472958
- OpenAlex
- W2626186519
- Cited by
- 175
- References
- 72
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 15 · 2023: 27 · 2022: 21 · 2021: 24 · 2020: 25 · 2019: 35 · 2018: 10
- FWCI
- 34.54
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Globalization and Health (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- University College London
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Public Health Policies and Epidemiology
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Public Health Policies and Education
- Social Sciences › Public Administration › Regulation and Compliance Studies
- Keywords
- non-communicable diseases, commercial determinants of health, primary prevention, public-private partnerships, public sector regulation, food and beverage industry, ultra-processed foods, global health architecture, health equity
- MeSH terms
- Noncommunicable Diseases, Chronic Disease, Commerce, Communicable Diseases, Government Agencies, Health Policy, Humans, Public Health, Risk, Tobacco Industry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure. https://app.cochat.ai/papers/10.1186/s12992-017-0255-3
- The paper
- Buse, K., Tanaka, S., & Hawkes, S. (2017). Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure. Globalization and Health. https://doi.org/10.1186/s12992-017-0255-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.